| [1] |
Würtz SO, Schrohl AS, Mouridsen H.TIMP-1 as a tumor marker in breast cancer--an update [J].Acta Oncol, 2008,47(4):580-590.
|
| [2] |
Fitzgibbons PL, Page DL, Weaver D, et al.Prognostic factors in breast cancer.College of American Pathologists Consensus Statement 1999[J].Arch Pathol Lab Med, 2000, 124(7):966-978.
|
| [3] |
Shimizu M, Saitoh Y, Itoh H.Immunohistochemical staining of Ha-ras oncogene product in normal, benign and malignant human pancreatic tissues [J].Hum Pathol, 1990,21(6):607-612.
|
| [4] |
Stetler Stevenson WG, Liotta LA, Kleiner DE Jr, et al.Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis[J].FASEB J, 1993, 7(15):1434-1441.
|
| [5] |
Pupa SM, Ménard S, Forti S, et al.New insights into the role of extracellular matrix during tumor onset and progression[J].J Cell Physiol,2002, 192(3):259-267.
|
| [6] |
Wartz S, Schrohl AS, Srensen NM, et al.Tissue inhibitor of metalloproteinases-1 in breast cancer[J].Endocr Relat Cancer, 2005,12(2):215-227.
|
| [7] |
Mushy FR, Issa R, Zhou X, et al.Inhibition of apoptosis of activated hepatic stelate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis[J].Biol Chem, 2002,277(13):11 069-11 076.
|
| [8] |
Vincenti MP.The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes.Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression[J].Methods Mol Biol, 2001,151:121-148.
|
| [9] |
McCarthy K, Maguire T, McGreal G, et al.High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer [J].Int J Cancer, 1999, 84(1):44-48.
|
| [10] |
Oelmann E, Herbst H, Zuhlsdorf M, et al.Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells[J].Blood, 2002,99(1):258-267.
|
| [11] |
Liu XW, Bernardo MM, Fridman R, et a1.Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase phosphati dylinositol 3-kinase and MAPK signaling pathway[J].Biol Chem, 2003,278(41):40 364-40 372.
|
| [12] |
Paradiso A, Tommasi S, Barletta A, et al.Metastatic site and p53 primary tumor expression in previously untreated stage IV breast cancer patients [J].Anticancer Res, 1999, 19(5):4523-4528.
|
| [13] |
Bouzubar N, Walker KJ, Griffiths K, et al.Ki67 immunostaining in primary breast cancer: pathological and clinical associations[J].Br J Cancer, 1989, 59(6): 943-947.
|
| [14] |
Wright C, Nicholson S, Angus B, et al.Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer [J].Br J Cancer, 1992, 65(1): 118-121.
|
| [15] |
Schrohl AS,Holten Andersen MN,Peters HA,et al.Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer[J].Clin Cancer Res,2004,10(7):2289-2298.
|